Early Phase
Global Clinical Development
Late Phase
Biometrics
Medical & Regulatory Affairs
Resourcing Solutions
SERVICES Early Phase Global Clinical Development Late Phase Biometrics Medical & Regulatory Affairs Resourcing Solutions
Global Clinical Development
Expediting Phase I to Phase IV projects worldwide on behalf of our clients requires meticulous planning, efficient project management and excellent communication skills to deal with a variety of cultures and local practices.
Chiltern’s Global Clinical Monitoring personnel ensure that the most up to date procedures and strict quality control are adhered to while working with the latest technology. Dedicated local line managers recruit, train and manage clinical monitoring staff to global standards and monitor quality to ICH-GCP, the clinical study protocol, client specific requests and Chiltern Standard Operating Procedures.
Our Global Project Managers are the client’s key liaison focused on global implementation. Working in partnership with clients, investigators and our project teams, the Global Project Managers make the decisions that deliver objectives quickly and efficiently. They perform risk analysis and develop solutions with contingencies for each project as part of our Connect Project Plan. As a result, they share a sense of ownership of the studies and accountability of the project milestones.
Chiltern Global Clinical Development capabilities:
Chiltern’s Global Clinical Monitoring personnel ensure that the most up to date procedures and strict quality control are adhered to while working with the latest technology. Dedicated local line managers recruit, train and manage clinical monitoring staff to global standards and monitor quality to ICH-GCP, the clinical study protocol, client specific requests and Chiltern Standard Operating Procedures.
Our Global Project Managers are the client’s key liaison focused on global implementation. Working in partnership with clients, investigators and our project teams, the Global Project Managers make the decisions that deliver objectives quickly and efficiently. They perform risk analysis and develop solutions with contingencies for each project as part of our Connect Project Plan. As a result, they share a sense of ownership of the studies and accountability of the project milestones.
Chiltern Global Clinical Development capabilities:
- Global teams located in Americas, Europe, Asia Pacific and South Africa
- Dedicated study teams in key therapeutic areas
- Clinical program development and management
- Project management
- Feasibility research
- Rapid study start up – Chiltern Activate
- Investigator and patient recruitment
- Clinical monitoring
- Safety management
- Site management and training
- Study supply management
- Drug accountability
In The Media
Chiltern Announces Its Financial Results For The Year Ended 31 March 2010, 27 July 2010 More
Follow the Project Leader, Chiltern Featured Article in the EPC June 2010 Issue , 30 June 2010 More
Chiltern Launches Collaborative Technologies, 10 June 2010 More
Chiltern Achieves Supplementary Accreditation from the Medicines and Healthcare products Regulatory Agency, 7 June 2010 More
Chiltern Announces Early Phase Partnership with Tayside Academic Health Sciences Centre, 2 June 2010 More

